Triple

T1182976
Position Surface form Disambiguated ID Type / Status
Subject Committee for Herbal Medicinal Products E25179 entity
Predicate subjectOf P38 FINISHED
Object European Union pharmaceutical legislation E130557 NE FINISHED

How this triple was built (2 steps)

Every LLM step that produced this triple, in pipeline order — named-entity classification, the disambiguation choices (the exact options shown, with the pick highlighted), and the generated description. The batch + timestamp of each is in the Provenance table below.

NER Named-entity recognition gpt-5-mini
Instruction
Given a phrase, classify it is english named entity (e.g., persons, organizations, works of art) in Latin script, or not (e.g., literals, dates, URLs, verbose phrases). For disambiguation, the statement where the phrase occurs as object is also given. Please return a JSON object with `phrase` (string, the phrase being analyzed) and `is_ne` (boolean, indicating whether the phrase is a Named Entity).
Input
Phrase: European Union pharmaceutical legislation | Statement: [Committee for Herbal Medicinal Products, subjectOf, European Union pharmaceutical legislation]
NED1 Entity disambiguation (via context triple) gpt-5-mini-2025-08-07 
Target entity: European Union pharmaceutical legislation
Context triple: [Committee for Herbal Medicinal Products, subjectOf, European Union pharmaceutical legislation]
  • A. European Union pharmaceutical legislation chosen
    European Union pharmaceutical legislation is the body of EU laws and regulations that governs the authorization, supervision, safety, and quality of medicines for human and veterinary use across member states.
  • B. European Union medical device regulations
    European Union medical device regulations are a comprehensive set of legal and technical requirements governing the safety, performance, quality management, and market approval of medical devices within EU member states.
  • C. European Medicines Agency
    The European Medicines Agency is the European Union’s regulatory authority responsible for the scientific evaluation, supervision, and safety monitoring of medicines for human and veterinary use.
  • D. European Directorate for the Quality of Medicines & HealthCare
    The European Directorate for the Quality of Medicines & HealthCare is a Council of Europe body responsible for developing quality standards and guidance to ensure the safety and efficacy of medicines and improve healthcare across member states.
  • E. International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use
    The International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use (ICH) is a global body that develops and promotes unified scientific and technical standards to ensure the safety, quality, and efficacy of medicines worldwide.
  • F. None of above.
  • G. Unsure - the case is ambiguous/there is not enough information to decide.

Provenance (3 batches)

The batch behind each pipeline step, in order, with when it ran. Timestamps are batch-level — stages were processed in waves, so the object chain (NER → NED1 → NEDg → NED2) reads in order, but predicate / elicitation batches can sit in a different wave.

Step Stage Batch ID Status When
creating Elicitation batch_69a494267b4c819088c97a59182bf56a completed March 1, 2026, 7:31 p.m.
NER Named-entity recognition batch_69a4bd35fb888190adf1e5d0615fa725 completed March 1, 2026, 10:27 p.m.
NED1 Entity disambiguation (via context triple) batch_69ac6f21547c81909cf23c454436e839 completed March 7, 2026, 6:32 p.m.
Created at: March 1, 2026, 7:45 p.m.